Atlas Trials

Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas

Clinical trial NCT00389077 · COMPLETED

Trial details

NCT number
NCT00389077
Sponsor
AEterna Zentaris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
TumorsLymphomas
Start date
2005-01-01
Primary completion
2011-07-01
Enrollment
558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.